SCHEMBL2928098

SCHEMBL2928098

O=C(O)Oc1csc(-c2ccncc2)n1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
KDM4E B2RXH2 6/20 0.47
KMT2A Q03164 3/20 0.47
AR P10275 2/20 0.47
CDK5 Q00535 2/20 0.47
CDK5R1 Q15078 2/20 0.47
CYP19A1 P11511 4/20 0.44
LMNA P02545 3/20 0.43
MAPT P10636 1/20 0.43
CDC7 O00311 1/20 0.43
DBF4 Q9UBU7 1/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 1/20 0.42
NLRP1 Q9C000 1/20 0.42
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350914 0.88 HDAC1 (0.51) KDM4EKMT2AARCDK5CDK5R1
SCHEMBL369872 0.83 CYP19A1 (0.59) KDM4ECYP19A1MAPTALDH1A1RAB9A
SCHEMBL5537850 0.78 KDM4E (0.60) HPGDKDM4EKMT2ALMNAMAPT
SCHEMBL4359699 0.76 GPR35 (0.40) ARALDH1A1
SCHEMBL4355345 0.76 TLR7 (0.51) HPGDKDM4EKMT2ACYP19A1LMNA
SCHEMBL2927311 0.76 KDM4E (0.53) KDM4ELMNAMAPTALDH1A1NPC1
SCHEMBL9390432 0.75 ALOX5 (0.54) KDM4ECDK5CDK5R1MAPTRAB9A
SCHEMBL28003513 0.75 CYP19A1 (0.60) HPGDKDM4EKMT2AARCDK5
SCHEMBL2926822 0.75 HDAC1 (0.55) HPGDKDM4ECYP19A1CDC7DBF4
SCHEMBL9053099 0.75 LMNA (0.43) HPGDKDM4ELMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP claimed
EP-2231652-B1 NOVEL 2-HETARYL THIAZOLE-4-CARBOXAMIDE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT Bayer Pharma AG (DE) 2012-05-30 EP disclosed
EP-2231652-A1 NOVEL 2-HETARYL THIAZOLE-4-CARBOXAMIDE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT Bayer Schering Pharma Aktiengesellschaft (DE) 2010-09-29 EP disclosed
WO-2009074246-A1 NOVEL 2-HETARYL THIAZOLE-4-CARBOXAMIDE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-06-18 WO disclosed
EP-2070924-A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine Bayer Schering Pharma Aktiengesellschaft (DE) 2009-06-17 EP disclosed